Iopamidol
Overview
Iopamidol is a small molecule active pharmaceutical ingredient (ChEMBL CHEMBL1200932).
API suppliers (7)
Suppliers of Iopamidol evidenced by a US FDA Type II Drug Master File or an EU Certificate of Suitability (CEP). Sources: FDA DMF list, EDQM certification database.
Country recorded for 3 of 7 suppliers.
3 of 7 hold a GMP certificate on record in the EU or UK registers
- Zhejiang Starry Pharmaceutical Co., LtdChina2 active DMF
- SUZHOU RYWAY BIOTECH CO LTD1 active DMF
- Divis LaboratoriesIndia1 active DMF GMP on record
- BRACCO IMAGING SPA1 active DMF GMP on record
- ZAMBON GROUP SPA
- HOVIONE SOCIEDADE QUIMICA SA
- RECORDATI INDUSTRIA CHIMICA E FARMACEUTICA SPAItaly GMP on record
Patent & exclusivity (US)
Per the FDA Orange Book (14 approved US products), the latest listed US patent on Iopamidol expires — and exclusivity 10 Oct 2028. Generic API sourcing typically opens up once these lapse.
Chemical identity
- IUPAC name
- 1-N,3-N-bis(1,3-dihydroxypropan-2-yl)-5-[[(2S)-2-hydroxypropanoyl]amino]-2,4,6-triiodobenzene-1,3-dicarboxamide
- Canonical SMILES
- C[C@@H](C(=O)NC1=C(C(=C(C(=C1I)C(=O)NC(CO)CO)I)C(=O)NC(CO)CO)I)O
- InChIKey
- XQZXYNRDCRIARQ-LURJTMIESA-N
Do you supply Iopamidol? Get in front of buyers actively sourcing it.
We route real sourcing requests from pharma buyers to vetted, verified partners — qualified leads, not just a listing. Tell us what you make and we'll be in touch about becoming a Verified Supplier Partner.
Ready to Accelerate Your
Discovery Workflow?
Find, vet, and source drug-manufacturing partners faster — with FDA compliance screening built in. Start free for 7 days.